Covenant Medical Center in Waterloo, Iowa, recently purchased and installed two Carestream Touch Prime XE Ultrasound Systems to capture radiology, OB/GYN, vascular, pediatric and interventional imaging studies. Covenant Medical Center is a 366-bed, full-service, multi-specialty hospital. A third Touch Prime Ultrasound XE system is deployed at Mercy Hospital, an affiliated critical access hospital in Oelwein, Iowa.

August 30, 2017 — ARTMS Products Inc. signed a strategic partnership with GE Healthcare around ARTMS’ proprietary QUANTM99 Irradiation System (QIS) for radioisotope production. The goal of the partnership is to supply equipment, technologies and research that supports the production and processing of radioisotopes on GE’s PETtrace 800 platform of medical cyclotrons.

iCAD Inc. announced that the company’s Xoft Axxent balloon applicators have received approval from the China Food & Drug Administration (CFDA) for the treatment of early-stage breast cancer. The Xoft Axxent balloon applicators are a key component of the Xoft Axxent Electronic Brachytherapy (eBx) System, which is used to perform intraoperative radiation therapy (IORT) in early-stage breast cancer patients who meet specific selection criteria.


August 30, 2017 — This is a list of the top breast imaging content so far for 2017. These articles and videos highlight all of the recent trends and recent clinical study data that is impacting women's healthcare. More information can also be found on ITN's "Breast Imaging" website channel.

Finding Value in Digital Breast Tomosynthesis


Radioembolization is a therapy method used for liver tumors that are uncurable with surgery or chemotherapy. Thorough development of an individual plan is important for successful treatment. Within the SIRTOP project, the Fraunhofer Institute for Medical Image Computing MEVIS in Bremen, Germany, is developing sophisticated computer algorithms to make therapy planning faster and more precise. The research team will present their initial results at several upcoming conferences.

August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of some linear gadolinium-based contrast agents (GBCAs) and suspending the marketing authorizations of others, while supporting the continued use of macrocyclic GBCAs.

A team of researchers recently used functional magnetic resonance imaging (fMRI) to investigate neural responses to food cues in overweight compared with lean adolescents. The team, including senior investigator Bradley Peterson, M.D., director of the Institute for the Developing Mind at Children’s Hospital Los Angeles, observed that food stimuli activated regions of the brain associated with reward and emotion in all groups. However, adolescents at an increasing risk for obesity had progressively less neural activity in circuits of the brain that support self-regulation and attention.

August 28, 2017 — Rayence Inc. announced the first multiple installations of a new Rayence cloud picture archiving and communication system (PACS) product through their channel partner, York X-Ray and Orthopedic Supply of Lyman, S.C.

20/20 GeneSystems Inc. recently released in China what is believed to be the world’s first machine learning algorithm commercialized for use in conjunction with blood tests to aid in the early detection of lung cancer. The cloud-accessible software, marketed in China by MyBioMed Ltd., is expected to be utilized over the next six months by at least 20 hospitals in five or more cities to help in distinguishing between benign versus malignant pulmonary nodules following computed tomography (CT) imaging.

August 28, 2017 — Philips Healthcare and HeartFlow Inc. announced they entered into a collaboration agreement to improve access to diagnostic and planning tools for interventional cardiologists evaluating and treating patients with suspected coronary artery disease (CAD).

Subscribe Now